26. The inspector observed a log of prescriptions that had the Respondent had
dispensed in 2018 and 2019. Included in the log were phentermine prescriptions that the
Respondent had dispensed through October 24, 2019, which contradicts the Respondent’s
statements made under oath to Board staff the following day that he had not dispensed
phentermine since approximately April 2019 (see § 24, above).

27. By letter dated January 23, 2020, the Board notified the Respondent that it
had opened in investigation into his dispensing practices based on the most recent OCSA
complaint and requested that he provide a written response.

28. On or about February 6, 2020, the Respondent provided his written
response to the OCSA complaint. The Respondent claimed that “the staff member
responsible for bringing us into full compliance . . . was let go in May 2019[.]” The
Respondent also noted that he has stopped dispensing all medications as of October 2019.

CONCLUSION OF LAW

Based on the foregoing Investigative Findings, Panel A concludes that the public
health, safety or welfare imperatively require emergency action in this case, pursuant to
Md. Code Ann., State Gov’t § 10-226(c)(2) (2014 Repl. Vol. & 2019 Supp.) and Md.
Code Regs. 10.32.02.08B(7){a).

ORDER

Based on the foregoing Investigative Findings and Conclusion of Law, it is, by a
majority of a quorum of Panel A, hereby

ORDERED that, pursuant to the authority vested in the Board by Md. Code Ann.,

State Gov’t § 10-226(c)(2) and Md. Code Regs. 10.32.02.08B(7)(a), the license of
